Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study.
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.
Alerting Network Dysfunction in Early Multiple Sclerosis.
Teriflunomide (Aubagio) approved for use by the NHS in Scotland and Northern Ireland
JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab.
One calcitriol dose transiently increases Helios(+)FoxP3(+) T cells and ameliorates autoimmune demyelinating disease.
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies: A Comparative Study.
Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.
The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Safety and efficacy of mitoxantrone in pediatric patients with aggressive multiple sclerosis.
Alemtuzumab for the Treatment of Multiple Sclerosis
A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis
Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
Selective inhibition of the mitochondrial permeability transition pore protects against neuro-degeneration in experimental multiple sclerosis.
Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.
Revimmune (High-Dose Cyclophosphamide) for Autoimmune Diseases
Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders.
Natalizumab Use During the Third Trimester of Pregnancy.
Necrotizing skin lesion and radial nerve palsy in a patient treated with glatiramer acetate.
Symptom changes in multiple sclerosis following psychological interventions: a systematic review.
Spin-offs: Meet the structure specialists
Glatiramer acetate, an anti-demyelination drug, reduced rats' epileptic seizures induced by pentylenetetrazol via protection of myelin sheath.
Individual axons regulate the myelinating potential of single oligodendrocytes in vivo.
Ustekinumab success in refractory Crohn’s disease
B cells and multiple sclerosis.

Pages